LK. Spleen cells were dissociated from groups of three to four CBA/~ mice that were unprimed or were infected with T. cn~zi 2-3 wk earlier as described (5, 6) . 10 spleen cells were cultured for 48 h in 6.5 ml Dulbecco's medium supplemented with 2% fetal calf serum, antibiotics, and 5 × 10 -5 2-mercaptoethanol in 100-mm tissue culture dishes (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.). Immune LK refers to medium from T. cruziimmune cells boosted with 6 × 106 heat-killed T. cru,zi (HKT) in vitro; control LK usually refers to nonimmune cells boosted with HKT. CBA Oa k) mice were used to generate LK because this strain does not react with the anti-Ia b'a reagent used in these experiments (see below). Therefore LK-induced changes on Ia b'd cells are Mq~ rather than LK derived. LK was added to peritoneal Mt h at a final concentration of 1-30% vol:vol and changed daily. Six different preparations of immune, and four preparations of control LK, were tested with similar effects. To determine if LK production required T cells, we treated spleen cells with a monoclonal rat anti-mouse Thy-1 (our clone B5-3) and complement (Rabbit LOTOX; Accurate Chemical & Scientific Corp., Hicksville, N. Y.) before culture with specific antigen.
Monodonal Antibodies. Five monoclonal rat anti-mouse reagents were used, all produced by hybridizing immune rat spleen with the mouse myeloma P3U-1, kindly supplied by Dr. M. Scharff, Albert Einstein College of Medicine, Bronx, N. Y. Clones were picked on soft agar, and antibody-rich ascites formed during growth in irradiated mice. Ig rich in monoclonal antibody was purified by passage over DEAE-cellulose. Three non-MHC reagents were derived by Dr. J. Unkeless, The Rockefeller University, New York, with rat spleen cells immune to the mouse M~ cell line J774. The three clones that react with all spleen and peritoneal Mth were: 1.21 J a clone that reacts with mouse M~ and granulocytes but not with most lymphocytes and DC and appears to be similar by immunoprecipitation analysis to clone Mac-1 described by Springer et al. (7) (8); 2.6, another clone that recognizes a 21,000-mol wt polypeptide found on mouse M~ (8) ; and 24G2 a clone that recognizes the IgG2b, or trypsin-resistant, Fc receptor (9) . An Fab fragment of clone 24G2 antibody, produced by papain cleavage, was used (9). The anti-major histocompatibility complex (MHC) reagents were produced in rats immunized with live BALB/c (H-2d) DC intravenously. Binding studies with iodinated monoclonal antibodies were performed on spleen cells of appropriate MHC congenic and recombinant strains. Clone lad d
B21-2 seems to be an anti I-A ' , and clone B25-1 an anti H-2D reagent (Table I) . Clone B21-2 immunoprecipitates typical class II polypeptides (10) and competes in sequential immunoprecipitation protocols with anti-Ia 8 (anti-I-Ab'd), but not anti-Ia 7 (anti-LEa'k), alloantisera obtained from the Research Resources Branch, National Institutes of Health, Bethesda, Md. Clone B25-1 precipitates typical class I (45 and 13 mol wt) polypeptides (10).
Binding125ofMonoclonal Antibodies. Each of the monoclonal reagents was lodmated' ' with carrierfree Na[ I] (New England Nuclear, Boston, Mass.; or Amersham/Searle, Arlington Heights, Ill.) to a level of 1-2 ~Ci//~g and stored as 20-50/~g/ml solutions in phosphate-buffered saline to which sodium azide (0.02%) and 1 mg/ml bovine serum albumin were added. Chloramine T or iodogen (Pierce Chemical Co., Rockford, Ill.) was used for iodination. Quantitative binding studies were performed on ice using cells adherent to 13-mm glass cover slips. Duplicate cover slips were exposed to 0.2 ml antibody at 0.2-1.0 #g/ml culture medium with 0.02% sodium azide. 1/~g/ml is at or close to the level required to saturate most binding sites for all antibodies. Equilibrium was reached within 30-60 min, after which the cover slips were rinsed through three successive changes of medium and fixed in 1.25% glutaraldehyde. The cover slips were counted (Autogamma 5220; Packard Instrument Co., Inc., Downers Grove, Ill.) and, when necessary, processed further for light microscope radioautography as described (3) . Controls for the specificity of binding in both quantitative and radioautographic assays included: (a) binding of the monoclonal was inhibited close to the background level by a 20-fold excess of unlabeled specific antibody; (b) binding was not inhibited if saturating levels of the anti-Fc receptor reagent, clone 24G2, were included during the binding assay; and (c) in the case of anti-MHC reagents, binding above the no cell background was not seen with Mq~ from the inappropriate haplotype, e.g., CBA. In all cases, background binding on cover slips without cells was <5-10% of specific binding. We suspect that the monoclonal antibodies have access to the M~ surfaces facing the culture medium and the culture vessel, because Dr. J. Michl, The Rockefeller University, (Personal communication.) has demonstrated that concanavalin A binds diffusely to the plasma membrane at 4°C.
TAnLE I

Binding of Monoclonal Anti-MHC Antibodies to Mouse Spleen
Major histocompatibility comAntibody bound by 2. After an additional 14 h, the monolayers were washed, lysed in 1.2 ml lysis buffer (8) , and clarified by centrifugation at 45,000 g for 15 rain at 4°C. An aliquot (2 × 106 cpm) was immunoprecipitated for 1 h at 4°C with a cocktail that contained 1 pgm each of monoclonal antibodies 1.21 J, B25-1, and 2.6. The immunoprecipitates were retrieved on protein ASepharose coated with immunoselected rabbit anti-rat Ig (N. L. Cappell Labs, Cochranville, Pa.). Another aliquot (10 × 106 cpm) was immunoprecipitated for 1 h on B21-2 coupled to cyanogen bromide-activated Sepharose 4B. The Sepharose beads were washed and solubilized as previously described (10) , and the antigens separated by 4-11% gradient sodium dodecyl sulfate-polyacrylamide gel electrophoresis. To quantitate the amount of labeled antigen, individual bands were excised, solubilized in 20% perchloric acid-20% hydrogen peroxide, and counted in the presence of Hydrofluor (National Diagnostics~Inc., Parsippany, N. J.).
Mixed Leukocyte Reactions (MLR). B6D2F1 irradiated stimulator Mff or DC (1,500 rad, Cs la7
source), were added to 16-mm tissue culture wells that contained 4.5 × 10 e nylon-wool-filtered responder DBA/2 spleen cells in 1 ml of RPMI-1640 medium supplemented with 1% responder mouse serum or 1% fetal calf serum. The cultures were maintained for 3-4 d, the cells were harvested, and then [nH]thymidine uptakes were measured in fresh medium as previously described (11) . In some cultures, indomethacin (1/~g/ml, Sigma Chemical Co., St. Louis, Mo.) was added to block synthesis of inhibitory M¢ prostaglandins (3, 12) . , all media were changed daily. In one additional set of cultures, the D10 medium was replaced by immune LK beginning at day 3 (A---A), whereas in another, the LK was removed by washing and replaced by DI0 at day 3 (0---0). Similar data to those illustrated from day 0-3 were obtained in seven consecutive experiments, whereas day 3-6 data were obtained in 3 consecutive experiments. Ftc 2E-G IfMq~ were cultured for 3 d in D10, so that >95% of the cells were Ia negative (Fig.  2E) , addition of LK again resulted in a re-expression of Ia on most ceils (Fig. 2F) . Enhanced binding was detected at 20 h, but not at 6 h (Fig. 1, A---A) . In another set of cultures, LK was added for 3 d and then removed by washing. Ia persisted on LKstimulated cells for at least 2 d and then fell ( Fig. 1 O--O) , in contrast to the shortlived nature of Ia on freshly explanted M~. We conclude that immune LK can induce most peritoneal M~ to express Ia in a stable form.
Results
Effect of LK on
Media from HKT-immune boosted spleen cells (immune LK) were compared to control media from nonimmune spleen cells. Control LK at doses of 5, 10 (Table II) , and 25% vol:vol (Fig. 3A) induced increases in Ia that were 20-50% that induced by immune LK. Somewhat larger increases were seen with media obtained from immune spleen not boosted with H K T (Table II) , but it is likely that 2-to 3-wk 72. cruzi- infected spleens harbor parasites. Kinetics studies in control LK showed that Ia first decreased and then was re-expressed usually at day 3 (Fig. 3 A) . By radioautography, it was determined that only a subpopulation of cells (20-40%) became Ia positive at all doses (Fig. 2 G) . If addition of control LK was delayed for 3 d, the Mq) still reexpressed Ia at a level of 30% that induced by immune LK (not shown). Treatment of immune or nonimmune spleen cells with anti-Thy-1 and complement before the culture period when LK was collected reduced LK activity by 60-90%. Finally, 2 samples of medium from concanavalin A-stimulated, nonimmune spleen cells were similar in activity to antigen-induced LK, causing a re-expression of Ia on most if not all cultured peritoneal M~ (data not shown).
Expression of Other Plasma Membrane Antigens In vitro.
To determine if the effects of immune and control LK were restricted to Ia, we performed quantitative binding studies ( Fig. 3 ; Table II ) with four other monoclonal antibodies (Materials and Methods). Radioautographic data are not presented, because these four monoclonal reagents detected antigens that were expressed to a similar extent on all cultured Mq~.
In contrast to Ia, expression of H-2D MHC determinants remained constant with culture at a level of 2 × 104-3 × 104 binding sites/cell. By day 2-3, both immune and control LK enhanced the level of H-2D, but immune LK usually induced larger and more rapid rises. The levels of 1.21 J antigen diminished 10-50% during culture in D10, but remained close to the starting level of 2.5 × 105-3.0 × 105 binding sites/cell in both immune or control LK. The trypsin-resistant Fc receptor (clone 24G2; 2 X l0 s binding sites/cell) remained constant with culture in D10 and increased up to twofold with immune or control LK. These increases closely paralleled total cell protein/cuhure. Finally 2.6 antigen (3 × 10~-4 × 10 4 binding sites/cell) increased two-to threefold during culture in D10 or in D10 with LK. In most experiments, the level of 2.6 was lowest in the presence of immune LK. We conclude that there is a wide range of behavior in the levels of plasma membrane antigens monitored simultaneously. The only moieties in which immune LK exerted selective enhancing effects were the MHC determinants--Ia and, to a lesser extent, H-2D.
Biosynthesis of Plasma Membrane Antigens. To determine if biosynthesis of Ia was
induced by LK, we performed immunoprecipitation studies on cells radiolabeled with [~S]methionine, usually on the third day of culture. Synthesis of Ia was readily detected in cells treated with immune LK (Fig. 4, lane 2) , whereas synthesis of Ia was diminished or absent in cells not exposed to LK (Fig. 4, lane 4) or exposed to control LK (Fig. 4, lane 6) . Synthesis of I-E-region alloantigens was also detected in LKtreated cells after immunoprecipitation with a (B I0 X HTI)F1 anti-B 10.A(5R) anti-Ia 7+ alloantiserum (data not shown).
To establish that radiolabeling of Ia antigens was selectively increased in LKtreated cells, we extended the immunoprecipitation analysis with three other monoclonal antibodies. The non-MHC-linked polypeptides (1.21 J, 180,000 and 95,000 mol wt and 2.6, 21,000 mol wt) were radiolabeled similarly in the presence or absence of LK in four consecutive experiments. The class 1 MHC polypeptides (clone B25-1, 45,000 and 13,000 mol wt) showed a relative increase in radiolabeling in cells exposed to immune LK (Fig. 4; compare lanes 1 with 3 and 5) . Because the radiolabeling of Ia (clone B21-2) and H-2D (clone B25-1) was increased relative to non-MHC plasma membrane antigens (clones 1.21 J and 2.6), we conclude that biosynthesis of MHC products is enhanced in LK-treated cells. (Table III) 3 and 4) , and 10% vol:vol control LK (lanes 5 and 6). Lysates were subject to immunoprecipitation with a cocktail of 1.21 J, B25-1, and 2.6 (lanes I, 3, and 5) or with clone B21-2 anti-Ia (lanes 2, 4, and 6). The labeled antigens were separated on 4-11% gradient gels and visualized by radioautography. The polypeptides recognized by each monoclonat antibody have been described (8, 10) MLR (3, 11) . In the other, we investigate mechanisms and specific changes consequent to the activation of M~ by immune cells and their products (4) (5) (6) . We report that LK from antigen-stimulated T. cruzi-immune spleen cells enhances the expression and synthesis of Mq, Ia in a dose-and time-dependent fashion. Increase in Ia joins a long list of Mq~ properties induced by this source of LK including: spreading, secretion of plasminogen activator, capacity to release hydrogen peroxide, and ability to kill T. cruzi and tumor cells (4) (5) (6) . These changes probably occur on most cells in the peritoneal Mq, population. Enhanced levels of Ia, like secretion of plasminogen activator (4), is particularly sensitive to the addition of LK. As a consequence, it is not surprising that control LK from nonirnmune spleen can exert similar but quantitatively less impressive changes. Nonimmune spleen may have cells sensitized to environmental antigens and may release the same mediators as immuneboosted cells. Alternatively, distinct factors may be present in control LK. We noted that the latter induced the expression of Ia only a subpopulation of cells, at all doses, in contrast to immune LK, which enhanced Ia on most, if not all cells (compare Fig.  2 C, F, and G) .
Stimulating Capacity of la-bearing Mep in the I ° MLR
In effect, expression of Ia on cultured peritoneal cells represents a surface marker that correlates with LK-induced M~ activation (4) (5) (6) . The level of Ia may be a simple, quantitative, and rapid assay ( Fig. 1 A---A; Fig. 2 E and F) for monitoring experiments characterizing the cells and mediators involved in the activation process. M~ obtained from the peritoneal cavities of immune-boosted mice also exhibit most parameters of Mq~ activation (13) and are strongly Ia positive (3, 14) . However in situ, these changes may be mediated by LK and other factors that act both in the tissues (peritoneal cavity) or during Mq~ development (marrow and peripheral blood).
The availability of monoclonal antibodies was critical for the execution of these experiments. Binding data with a battery of monoclonal reagents indicated that expression of Ia, and to a lesser extent H-2D, was selectively enhanced by immune LK. The expression of three other plasma membrane antigens, detected by clones 1.21 J, 2.6, and 24G2, was not appreciably altered by immune relative to control LK ( Fig. 3 and Table II ). Similar quantitative data would be difficult to obtain from small numbers of adherent cells using cytotoxicity, indirect immunofluorescence, or absorption assays. In biosynthesis studies (Fig. 4) , radiolabeling of Ia was selectively increased by immune LK, whereas radiolabeling of non-MHC polypeptides recognized by clones 1.21 J and 2.6 was similar in all cultures. Using the latter polypeptides as controls, we concluded that radiolabeling of Ia reflects an induction of Ia biosynthesis. Finally, the rat anti-mouse monoclonal antibody clone B2 I-2 is specific for the Ia b'd haplotype (Table I) . Binding above the no-cell background was only seen on Ia b'd cells treated with LK [e.g., C57BL/6, DBA/2, C6D2F1, B10A(5R)] and not Ia k M~ (CBA; Fig. 2 C and D) . By using LK from T. cruzi-immune CBA spleen cells, we ensured that the increase in Ia we observed was derived from the treated Mq~ and not adsorbed from the applied LK.
It is not clear if all members of the mononuclear phagocyte lineage increase Ia in response to LK. Our studies utilized proteose-peptone-elieited cells, because this population reproducibly (15 consecutive experiments) increased Ia in the manner reported here. Less dramatic increases in Ia were usually found in LK-treated, resident peritoneal, and spleen M~. Tissue culture itself also seemed to enhance susceptibility to LK. It took 24-48 h for LK to induce large increases in Ia on freshly explanted Mff, whereas cells that had been cultured 2-3 d exhibited one-half-maximal responses by 20 h (Fig. 1) . Possibly, fetal calf serum and/or endotoxin contribute to the enhanced responsiveness of cultured Mth (15) .
Several factors may contribute to enhanced levels of Ia. A primary mechanism seems to be the induction of biosynthesis in Mq~ exposed to LK. (Fig. 4) . Other alterations that might occur in the presence of LK include: decreased degradation rates of pre-existing Ia; mobilization of Ia from pre-formed intracellular pools; and increased accessibility of surface Ia to the 12SI-anti-Ia probe.
Ia on freshly explanted peritoneal M~b exhibits several differences from Ia induced by immune LK. Endogenous Ia is heterogeneous in its distribution and short-lived in vitro, whereas LK-induced Ia is found on most cells and is more long-lived. The rapid and selective loss of Ia from the surface of peritoneal Mtk is a puzzling finding. Other plasma membrane constituents turnover much more slowly with a tl/2 of >24 h (16) . Ia on explanted peritoneal cells may be analogous to myeloperoxidase; that is, it is actively synthesized by immature mononuclear phagocytes, persists for a finite period after cessation of synthesis, and then diminishes rapidly.
Previous studies on cultured rodent M~ have emphasized that Ia is a stable phenotype for a Mq~ subpopulation. However, most Mth Ia disappears rapidly from the cell surface during culture. LK then induces Ia on virtually all cells. These findings indicate that Ia on tissues Mth is not a constitutive trait. Like many other Mth properties, Ia may be altered by environmental factors, including tissue culture and immunologic stimuli.
How then would increased expression of Mth Ia contribute to the cellular immune response and to the biologic effects of LK? One hypothesis is that Ia is able to form some sort of complex with antigen (antigen processing or presentation) that is required for T cell stimulation. We did not test this possibility directly, but we did examine the ability of Ia-bearing Mth to stimulate a proliferative response in allogeneic T ceils. The M~ were inactive, even when indomethacin was added to diminish the synthesis of inhibitory prostaglandins (Table III) . Conceivably, LK-induced Mq~ inhibit their own functional capacities in vitro by an indomethacin-insensitive process. This is unlikely, because DC were fully capable of triggering the MLR in the presence of these Mff. Our data thus extend previous observations on the different functional properties of Ia-bearing DC and Ia-positive Mth generated in situ (3, 10) . Ia on the surface of Mq~ may be intrinsically different from Ia on the surface of DC, or additional non-MHC factors are utilized by DC in functional assays.
We favor the idea that increased expression of Ia, and possibly H-2K/D, enhances the ability of T cells to interact directly with M4,. The T cells that secrete LK and that activate M~ are likely to be selected to recognize self-MHC determinants. Direct T-Mq~ interaction would enable the T cells and/or LK products to more efficiently activate Mtb function. The initial generation of MHC-restricted effector ceils however may be mediated by Ia-bearing DC (3). A similar requirement for MHC products mediating T-B interaction during B cell activation has been proposed (17) .
Summary
Soluble products from antigen stimulated T~ypanosoma cruzi-immune spleen cells enhanced the expression of Ia antigens on proteose-peptone-elicited mouse peritoneal macrophages (M~b). Acquisition of Ia paralleled Mq~ activtion, previously shown to be mediated by this same source of lymphokine (LK).
Expression of Ia and four other plasma membrane antigens was monitored by quantitative binding and radioautographic studies with l~SI-monoclonal antibodies. Immune LK selectively enhanced expression of Ia and, to a lesser extent, H-2D relative to control LK from antigen-stimulated noninfected spleen. The levels of three other non-major histocompatibility complex (MHC) antignes, including the trypsinresistant Fc receptor, were similar in cells exposed to both sources of LK. As little as 1% immune LK induced one-half maximal expression of Ia. Kinetic studies revealed that much of the Ia on freshly explanted peritoneal Mg} was lost during the 1st d of culture. In the continued presence of immune LK, Ia was re-expressed on virtually all M~ by the 2nd and 3rd d. Alternatively, >95% Ia negative populations were obtained by culturing the cells 3 d; then, addition of LK induced Ia on most cells within 1 d. Once induced, Ia persisted on the M4} surface for at least 2 d.
[35S]methionine radiolabeling indicated that immune LK selectively increased radiolabeling of M~ Ia, again with other non-MHC-linked plasma membrane polypeptides as controls.
LK-induced Ia-bearing M~ were tested as primary mixed leukocyte reaction stimulators. 1 × 10°-2 × 10 s Mth did not stimulate 4.5 × 10 6 responding T cells, whereas 10 4 dendritic cells induced strong responses, as previously described. Because Ia-positive Mth do not actively sensitize T cells in a model immune response, we propose that Mth MHC products serve primarily as recognition sites for previously sensitized T cells, thereby enhancing T cell-mediated Mth activation.
